CN112972769B - Method for preparing nano-silver-containing antibacterial peptide functional coating on metal surface - Google Patents
Method for preparing nano-silver-containing antibacterial peptide functional coating on metal surface Download PDFInfo
- Publication number
- CN112972769B CN112972769B CN202110193466.8A CN202110193466A CN112972769B CN 112972769 B CN112972769 B CN 112972769B CN 202110193466 A CN202110193466 A CN 202110193466A CN 112972769 B CN112972769 B CN 112972769B
- Authority
- CN
- China
- Prior art keywords
- silver
- nano
- antibacterial peptide
- mixed solution
- metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims abstract description 100
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 93
- 238000000576 coating method Methods 0.000 title claims abstract description 65
- 239000011248 coating agent Substances 0.000 title claims abstract description 59
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 58
- 239000002184 metal Substances 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 29
- 239000011259 mixed solution Substances 0.000 claims abstract description 65
- 108010022355 Fibroins Proteins 0.000 claims abstract description 59
- 239000000243 solution Substances 0.000 claims abstract description 47
- 229920001690 polydopamine Polymers 0.000 claims abstract description 31
- 239000002245 particle Substances 0.000 claims abstract description 24
- CTENFNNZBMHDDG-UHFFFAOYSA-N Dopamine hydrochloride Chemical compound Cl.NCCC1=CC=C(O)C(O)=C1 CTENFNNZBMHDDG-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960001149 dopamine hydrochloride Drugs 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 14
- 229910052709 silver Inorganic materials 0.000 claims abstract description 14
- 239000004332 silver Substances 0.000 claims abstract description 14
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 14
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000009467 reduction Effects 0.000 claims abstract description 11
- 239000007983 Tris buffer Substances 0.000 claims abstract description 9
- -1 silver ions Chemical class 0.000 claims abstract description 9
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 7
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical group [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 25
- 239000010936 titanium Substances 0.000 claims description 25
- 229910052719 titanium Inorganic materials 0.000 claims description 25
- 239000012224 working solution Substances 0.000 claims description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000008367 deionised water Substances 0.000 claims description 17
- 229910021641 deionized water Inorganic materials 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 8
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 7
- 239000010935 stainless steel Substances 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000004506 ultrasonic cleaning Methods 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 abstract description 11
- 230000007774 longterm Effects 0.000 abstract description 11
- 230000001954 sterilising effect Effects 0.000 abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 7
- 239000006185 dispersion Substances 0.000 abstract description 5
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 89
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 89
- 230000000844 anti-bacterial effect Effects 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 10
- 239000011550 stock solution Substances 0.000 description 10
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 206010059866 Drug resistance Diseases 0.000 description 5
- 208000022362 bacterial infectious disease Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 208000035143 Bacterial infection Diseases 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 230000000399 orthopedic effect Effects 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 206010011409 Cross infection Diseases 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 206010031256 Osteomyelitis chronic Diseases 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000011641 antimicrobial peptide production Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- COEZWFYORILMOM-UHFFFAOYSA-N sodium 4-[(2,4-dihydroxyphenyl)diazenyl]benzenesulfonic acid Chemical compound [Na+].OC1=CC(O)=CC=C1N=NC1=CC=C(S(O)(=O)=O)C=C1 COEZWFYORILMOM-UHFFFAOYSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/06—Coatings containing a mixture of two or more compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Abstract
Description
技术领域technical field
本发明属于生物医用材料领域,具体涉及一种金属表面制备含纳米银抗菌肽功能涂层的方法。The invention belongs to the field of biomedical materials, and in particular relates to a method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface.
背景技术Background technique
医用纯钛以其优异的生物相容性已经被广泛应用于临床医学领域中。早在20世纪50年代,纯钛就被加工成骨板、骨钉、股骨头等植入医疗器械用于骨科修复手术中。然而,作为常见的术后并发症,有关医用医疗器械引发的细菌感染已经成为21世纪医学领域内亟待解决的重要问题之一。据报道,美国骨科植入物相关感染的年发病率就达到4.3%左右。根据世界卫生组织(WHO)颁布的《院内感染防治实用手册》中的有关数据,每天全世界有超过1400万人在遭受院内感染的痛苦,其中60%的细菌感染与使用的医疗器械有关。骨科等术后感染会直接造成患者伤口经久不愈,经常会导致手术失败,甚至导致慢性骨髓炎等并发症,不仅给患者带来了巨大的身心痛苦和沉重的经济负担,也会对医院和社会等造成不同程度的负面影响。因此,在医用钛合金表面构建载抗菌剂(抗生素、抗菌肽、纳米银等)的功能涂层,对于消除或减少相关医疗器械引发的细菌感染性疾病具有重大的社会和经济意义。Medical pure titanium has been widely used in the field of clinical medicine because of its excellent biocompatibility. As early as the 1950s, pure titanium was processed into bone plates, bone nails, femoral heads and other implanted medical devices for orthopedic repair operations. However, as a common postoperative complication, bacterial infection caused by medical devices has become one of the important problems to be solved in the field of medicine in the 21st century. According to reports, the annual incidence of orthopedic implant-related infections in the United States reaches about 4.3%. According to the relevant data in the "Practical Handbook of Nosocomial Infection Prevention and Control" promulgated by the World Health Organization (WHO), more than 14 million people around the world suffer from nosocomial infections every day, and 60% of bacterial infections are related to the use of medical devices. Postoperative infection in orthopedics will directly cause the patient's wound to not heal for a long time, often lead to operation failure, and even lead to complications such as chronic osteomyelitis. society, etc., causing varying degrees of negative impacts. Therefore, constructing functional coatings loaded with antibacterial agents (antibiotics, antimicrobial peptides, nano-silver, etc.) on the surface of medical titanium alloys has great social and economic significance for eliminating or reducing bacterial infectious diseases caused by related medical devices.
目前,得益于高效可靠的杀菌能力,抗生素仍是使用最为广泛的传统抗菌剂,但是抗生素容易引起细菌的耐药性,导致更为严重的耐药菌感染问题。相比之下,纳米银与抗菌肽不易引起细菌的耐药性,且能广谱抗菌和长期有效抑制生物膜,因此有很大的潜力取代抗生素。与其他的存在形式相比,由于金属离子的洗脱作用和纳米颗粒的杀菌性质的综合作用,纳米银具有更高的抗菌活性。目前普遍认为纳米银具有复杂的抗菌机理:其可以粘附在细菌表面上,从而改变细菌细胞膜通透性;其可以通过与含硫醇的蛋白质相互作用来杀菌;其可以与细菌DNA结合并破坏其功能;特别的,纳米银可以释放出具有杀菌能力的银离子。由于具有多种生物活性,目前抗菌肽己成为生物分子与生物材料的研究热点。在直接针对细菌与真菌引起的感染时,抗菌肽的抗菌效率较高。目前在生物医用材料中,抗菌肽受到越来越多的关注,主要作为表面修饰抗菌成分或作为被运载的抗菌药物用于局部释放。At present, antibiotics are still the most widely used traditional antibacterial agents due to their efficient and reliable bactericidal ability, but antibiotics are prone to cause bacterial resistance, leading to more serious infections caused by drug-resistant bacteria. In contrast, nano-silver and antimicrobial peptides are not easy to cause bacterial drug resistance, and can have broad-spectrum antibacterial and long-term effective inhibition of biofilm, so they have great potential to replace antibiotics. Compared with other existing forms, silver nanoparticles have higher antibacterial activity due to the combined effect of the elution of metal ions and the bactericidal properties of nanoparticles. It is generally believed that nano-silver has a complex antibacterial mechanism: it can adhere to the surface of bacteria, thereby changing the permeability of bacterial cell membranes; it can kill bacteria by interacting with thiol-containing proteins; it can bind to bacterial DNA and destroy bacteria. Its function; in particular, nano-silver can release silver ions with bactericidal ability. Antimicrobial peptides have become a research hotspot in biomolecules and biomaterials due to their various biological activities. Antimicrobial peptides have higher antibacterial efficiency when directly targeting infections caused by bacteria and fungi. At present, in biomedical materials, antimicrobial peptides have received more and more attention, mainly as surface-modified antibacterial components or as carried antibacterial drugs for local release.
丝素蛋白是蚕丝的主体,是一种无生理活性的天然生物大分子。丝素蛋白质与其他天然高分子相比有明显的优越性,研究表明它具有良好的生物相容性、无毒、无污染、无刺激性、可生物降解。近年来,丝素蛋白由于其良好的生物相容性逐渐应用于生物传感、生物医学材料、软组织相容材料、组织工程等领域。特别的,丝素蛋白具有还原性,可以原位还原得到纳米银和抗菌肽颗粒,避免了有毒的还原剂的使用。Silk fibroin is the main body of silk and a natural biological macromolecule without physiological activity. Compared with other natural polymers, silk fibroin protein has obvious advantages. Studies have shown that it has good biocompatibility, non-toxic, non-polluting, non-irritating, and biodegradable. In recent years, due to its good biocompatibility, silk fibroin has been gradually used in biosensing, biomedical materials, soft tissue compatibility materials, tissue engineering and other fields. In particular, silk fibroin has reducing properties, and can be reduced in situ to obtain nano-silver and antimicrobial peptide particles, avoiding the use of toxic reducing agents.
目前,常见的载抗生素的涂层容易引起细菌的耐药性,不能应对更高细菌浓度或更强细菌活性的细菌感染环境,且高浓度的抗菌剂会产生潜在的生物毒性,如何在低浓度用量下达到长期高效的抗菌效果成为挑战。At present, common antibiotic-loaded coatings are likely to cause bacterial resistance, and cannot cope with bacterial infection environments with higher bacterial concentrations or stronger bacterial activity, and high concentrations of antibacterial agents will produce potential biological toxicity. It is a challenge to achieve long-term and high-efficiency antibacterial effect under dosage.
发明内容Contents of the invention
本发明所要解决的技术问题在于针对上述现有技术的不足,提供一种金属表面制备含纳米银抗菌肽功能涂层的方法。该方法采用紫外照射法利用丝素蛋白将银离子还原成纳米银,有效控制了纳米银粒子的粒径大小和形貌,且抗菌肽与纳米银之间形成配位键,促进抗菌肽在纳米银颗粒表面富集,使得表面富集抗菌肽的纳米银在含纳米银抗菌肽功能涂层内呈现纳米级分散态,有利于实现低抗菌剂用量下长期高效杀菌。The technical problem to be solved by the present invention is to provide a method for preparing a nano-silver antimicrobial peptide-containing functional coating on a metal surface in view of the above-mentioned deficiencies in the prior art. The method uses silk fibroin to reduce silver ions to nano-silver by ultraviolet irradiation, effectively controlling the particle size and shape of nano-silver particles, and forming a coordination bond between the antimicrobial peptide and nano-silver to promote the antimicrobial peptide in nano-silver. The surface enrichment of silver particles makes the nano-silver enriched with antimicrobial peptides on the surface present a nano-scale dispersion state in the functional coating containing nano-silver antimicrobial peptides, which is conducive to the realization of long-term and high-efficiency sterilization with low antibacterial agent dosage.
为解决上述技术问题,本发明采用的技术方案为:一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,该方法包括以下步骤:In order to solve the above-mentioned technical problems, the technical solution adopted in the present invention is: a method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface, characterized in that the method comprises the following steps:
步骤一、将硝酸银粉末和抗菌肽粉末加入到丝素蛋白溶液中混合,得到含有丝素蛋白、银离子和抗菌肽的混合溶液A;所述混合溶液A中丝素蛋白的质量浓度为2%~5%,银离子的浓度为1mg/mL~20mg/mL,抗菌肽的浓度为0.4mg/mL~1mg/mL;
步骤二、将步骤一中得到的混合溶液A放置于紫外灯下进行照射还原,使得混合溶液A的颜色逐渐由乳白色变为深棕色,得到含有丝素蛋白、纳米银和抗菌肽的混合溶液B;所述照射还原的时间为0.5h~2h;Step 2. Place the mixed solution A obtained in
步骤三、采用标准NaOH溶液将10mM的Tris溶液标定至pH为8.5,然后加入盐酸多巴胺得到工作液,再将金属浸入工作液中在避光条件下浸泡12h~24h,得到表面具有聚多巴胺辅助层的金属;Step 3: Use standard NaOH solution to calibrate the 10mM Tris solution to pH 8.5, then add dopamine hydrochloride to obtain the working solution, and then immerse the metal in the working solution for 12h-24h under dark conditions to obtain an auxiliary layer of polydopamine on the surface Metal;
步骤四、将步骤三中得到的表面具有聚多巴胺辅助层的金属浸入步骤二中得到的混合溶液B中进行浸泡,在金属表面形成含纳米银抗菌肽功能涂层。Step 4, immerse the metal having the polydopamine auxiliary layer on the surface obtained in step 3 into the mixed solution B obtained in step 2 to form a functional coating containing nano-silver antimicrobial peptide on the metal surface.
本发明首先采用紫外照射的还原方法,使得丝素蛋白对银离子进行还原,通过控制关键工艺参数包括丝素蛋白的浓度、银离子浓度、照射还原时间,有效控制纳米银粒子的粒径大小和形貌,得到分散良好粒径均一的纳米银颗粒,且抗菌肽与纳米银之间形成配位键,促进抗菌肽在纳米银颗粒表面富集,从而使得表面富集抗菌肽的纳米银在丝素蛋白基含纳米银抗菌肽功能涂层内呈现纳米级分散态,提高了杀菌效率,大大缩短了制备时间,实现了低抗菌剂用量即低抗菌肽和低纳米银用量下长期高效杀菌;然后在金属基底表面引入聚多巴胺辅助层,并采用浸泡的方法使得载纳米银(表面富集抗菌肽)的丝素蛋白基含纳米银抗菌肽功能涂层通过聚多巴胺辅助层结合在金属基底表面,在金属表面形成含纳米银抗菌肽功能涂层,解决了含纳米银抗菌肽功能涂层与金属基底之间结合性差的问题,提高了纳米银抗菌肽功能涂层与金属表面的结合效果。同时,由于含纳米银抗菌肽功能涂层中的纳米银与抗菌肽均具有高效的杀菌能力,尤其是抗菌肽具有独特的杀菌机理,通常会破坏微生物细胞膜的完整性,在不激活适应性免疫的情况下迅速杀死入侵的微生物,有效避开了细菌的遗传适应机制,从而不引起耐药性,且纳米银与抗菌肽两者之间存在协同效应,并在植入位置长期可控释放,赋予了含纳米银抗菌肽功能涂层长期高效杀菌的能力,有效地解决了植入物相关的细菌感染问题,且不会引起细菌的耐药性,降低了抗菌肽的浓度;另外,由于丝素蛋白具有良好的人体亲和性、生物相容性、无毒、且利于细胞粘附,而低浓度纳米银粒子的骨诱导性提供了优异的成骨诱导能力,因此,本发明在金属(尤其是钛金属)表面制备的含纳米银抗菌肽功能涂层具有良好的生物相容性和骨诱导性,适用性好,应用价值高。The present invention first adopts the reduction method of ultraviolet irradiation, so that silk fibroin can reduce silver ions, and by controlling the key process parameters including the concentration of silk fibroin, silver ion concentration, and irradiation reduction time, the particle size and size of nano-silver particles can be effectively controlled. The morphology of silver nanoparticles with good dispersion and uniform particle size is obtained, and the coordination bond is formed between the antimicrobial peptide and the silver nanoparticle, which promotes the enrichment of the antimicrobial peptide on the surface of the silver nanoparticle, so that the silver nanoparticle enriched with the antimicrobial peptide on the surface The protein-based functional coating containing nano-silver antibacterial peptides presents a nano-scale dispersion state, which improves the sterilization efficiency, greatly shortens the preparation time, and realizes long-term high-efficiency sterilization with low antibacterial agent dosage, that is, low antimicrobial peptide and low nano-silver dosage; and then Introduce a polydopamine auxiliary layer on the surface of the metal substrate, and use the method of soaking to make the silk fibroin-based functional coating containing nano-silver (surface-rich antibacterial peptide) be combined on the surface of the metal substrate through the polydopamine auxiliary layer, Forming a nano-silver antimicrobial peptide functional coating on the metal surface solves the problem of poor binding between the nano-silver antimicrobial peptide functional coating and the metal substrate, and improves the binding effect between the nano-silver antimicrobial peptide functional coating and the metal surface. At the same time, since the nano-silver and the antimicrobial peptide in the nano-silver antimicrobial peptide functional coating have high-efficiency bactericidal ability, especially the antimicrobial peptide has a unique bactericidal mechanism, which usually destroys the integrity of the microbial cell membrane, without activating the adaptive immunity. Rapidly kill the invading microorganisms in the absence of bacteria, effectively avoiding the genetic adaptation mechanism of bacteria, so as not to cause drug resistance, and there is a synergistic effect between nano silver and antimicrobial peptides, and long-term controllable release at the implantation site , which endows the nano-silver antimicrobial peptide functional coating with the ability of long-term and efficient sterilization, effectively solves the problem of implant-related bacterial infection, and does not cause bacterial drug resistance, and reduces the concentration of antimicrobial peptides; in addition, due to Silk fibroin has good human affinity, biocompatibility, non-toxicity, and is beneficial to cell adhesion, and the osteoinductivity of low-concentration nano-silver particles provides excellent osteoinductive ability, therefore, the present invention is in metal The nano-silver antibacterial peptide-containing functional coating prepared on the surface of (especially titanium metal) has good biocompatibility and osteoinductivity, good applicability and high application value.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤二中所述混合溶液B中纳米银的粒径为20nm~500nm,混合溶液B中具有β折叠结构的丝素蛋白的质量含量为15%~30%。该优选粒径保证了纳米银的最佳抗菌效果;优选的具有β折叠结构的丝素蛋白的质量含量提高了混合溶液B的稳定性,进而保证了在金属表面形成的含纳米银抗菌肽功能涂层的稳定性。The above-mentioned method for preparing a functional coating containing nano-silver antimicrobial peptides on a metal surface is characterized in that the particle size of nano-silver in the mixed solution B described in step 2 is 20nm to 500nm, and the mixed solution B has a β-sheet structure The mass content of silk fibroin is 15%-30%. The preferred particle size ensures the best antibacterial effect of nano-silver; the preferred quality content of silk fibroin with a β-sheet structure improves the stability of the mixed solution B, thereby ensuring the nano-silver antibacterial peptide function formed on the metal surface coating stability.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤二中所述混合溶液A中抗菌肽的氨基酸序列为(NH2)-NGIVKAGPAIAVLGEAAL-CONH2,抗菌肽的质量纯度大于99%。该优选的抗菌肽具有特异性高效杀菌性,不易引起细菌的耐药性。The above-mentioned method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface is characterized in that the amino acid sequence of the antimicrobial peptide in the mixed solution A described in step 2 is (NH 2 )-NGIVKAGPAIAAVLGEAAL-CONH 2 , the antimicrobial peptide The mass purity is greater than 99%. The preferred antimicrobial peptide has specific and high-efficiency bactericidal properties, and is not easy to cause bacterial drug resistance.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤三中所述金属为钛、钛合金或不锈钢。本发明的制备方法应用范围广泛,适用于多种常见医用金属。The above-mentioned method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface is characterized in that the metal in step 3 is titanium, titanium alloy or stainless steel. The preparation method of the invention has a wide range of applications and is applicable to various common medical metals.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤三中所述工作液中盐酸多巴胺的浓度为1mg/mL~4mg/mL。The above-mentioned method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface is characterized in that the concentration of dopamine hydrochloride in the working solution in step 3 is 1 mg/mL-4 mg/mL.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤三中所述金属浸入工作液前先进行清洗预处理:将金属依次浸入丙酮、乙醇和去离子水中超声清洗15min。该优选的清洗工艺去除了金属表面杂质和污染物,有利于多巴胺在金属表面聚合形成聚多巴胺辅助层。The above-mentioned method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface is characterized in that the metal described in step 3 is first cleaned and pretreated before being immersed in the working solution: the metal is sequentially immersed in acetone, ethanol and deionized water. Wash for 15 minutes. This preferred cleaning process removes impurities and pollutants on the metal surface, and is conducive to the polymerization of dopamine on the metal surface to form a polydopamine auxiliary layer.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤三中所述聚多巴胺辅助层的厚度为200nm~500nm。该优选厚度的聚多巴胺辅助层保证了金属与含纳米银抗菌肽功能涂层之间的结合效果。The above method for preparing a functional coating containing nano-silver antibacterial peptide on a metal surface is characterized in that the thickness of the polydopamine auxiliary layer in step 3 is 200nm-500nm. The preferred thickness of the polydopamine auxiliary layer ensures the bonding effect between the metal and the functional coating containing the nano-silver antimicrobial peptide.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤四中所述表面具有聚多巴胺辅助层的金属浸入步骤二中得到的混合溶液B中浸泡后取出放置于恒温干燥箱中,在60℃下干燥10min~30min。通过该干燥工艺促进了丝素蛋白形成稳定结构,有利于提高金属与含纳米银抗菌肽功能涂层的结合性能。The above-mentioned method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface is characterized in that the metal having a polydopamine auxiliary layer on the surface described in step 4 is soaked in the mixed solution B obtained in step 2 and then taken out and placed in In a constant temperature drying oven, dry at 60°C for 10min to 30min. The drying process promotes the formation of a stable structure of the silk fibroin, which is beneficial to improving the binding performance of the metal and the nano-silver antibacterial peptide-containing functional coating.
上述的一种金属表面制备含纳米银抗菌肽功能涂层的方法,其特征在于,步骤四中所述含纳米银抗菌肽功能涂层的厚度为1μm~20μm。The above-mentioned method for preparing a functional coating containing nano-silver antimicrobial peptide on a metal surface is characterized in that the thickness of the functional coating containing nano-silver antimicrobial peptide in step 4 is 1 μm to 20 μm.
本发明与现有技术相比具有以下优点:Compared with the prior art, the present invention has the following advantages:
1、本发明采用紫外照射法利用丝素蛋白将银离子还原成纳米银,有效控制了纳米银粒子的粒径大小和形貌,且抗菌肽与纳米银之间形成配位键,促进抗菌肽在纳米银颗粒表面富集,使得表面富集抗菌肽的纳米银在含纳米银抗菌肽功能涂层内呈现纳米级分散态,有利于实现低抗菌剂用量下长期高效杀菌。1. The present invention utilizes silk fibroin to reduce silver ions to nano-silver by ultraviolet irradiation, effectively controlling the particle size and shape of nano-silver particles, and forming a coordination bond between the antimicrobial peptide and nano-silver to promote antimicrobial peptide production. The enrichment on the surface of nano-silver particles makes the nano-silver enriched with antimicrobial peptides on the surface present a nano-scale dispersion state in the functional coating containing nano-silver antimicrobial peptides, which is conducive to achieving long-term high-efficiency sterilization with low antibacterial agent dosage.
2、本发明通过在金属基底表面引入聚多巴胺辅助层,提高了纳米银抗菌肽功能涂层与金属表面的结合效果,解决了含纳米银抗菌肽功能涂层与金属基底之间结合性差的问题,有利于发挥其作为金属植入体长期高效的协同杀菌作用。2. The present invention improves the bonding effect between the nano-silver antimicrobial peptide functional coating and the metal surface by introducing a polydopamine auxiliary layer on the surface of the metal substrate, and solves the problem of poor bonding between the nano-silver antimicrobial peptide functional coating and the metal substrate , which is conducive to exerting its long-term and efficient synergistic bactericidal effect as a metal implant.
3、本发明金属表面形成的含纳米银抗菌肽功能涂层中的纳米银与抗菌肽均具有高效的杀菌能力,且两者之间存在协同效应,并在植入位置长期可控释放,达到降低抗菌肽用量(远低于其生物毒性临界浓度)和长期高效杀菌的目的,解决了细菌耐药性的问题。3. Both the nano-silver and the antimicrobial peptide in the functional coating containing nano-silver antibacterial peptide formed on the metal surface of the present invention have high-efficiency bactericidal ability, and there is a synergistic effect between the two, and they can be released in a long-term controllable manner at the implanted position, reaching The purpose of reducing the dosage of antimicrobial peptides (far below the critical concentration of its biological toxicity) and long-term high-efficiency sterilization solves the problem of bacterial drug resistance.
4、本发明在金属表面制备的含纳米银抗菌肽功能涂层具有良好的生物相容性和骨诱导性,植入生物体后抑制了原有骨的吸收过程并促进新骨生成,实现矫形移植器件(假体)与周围骨组织快而好的整合目的,且有效防止了细菌引起的植入感染,增长其服役期,尤其适用于具有病理诱发骨吸收及骨折患者的治疗,适用性好,应用价值高。4. The nano-silver antimicrobial peptide functional coating prepared on the metal surface of the present invention has good biocompatibility and osteoinductivity, and after being implanted into the organism, it inhibits the resorption process of the original bone and promotes the formation of new bone, realizing orthopedic The purpose of fast and good integration between the implanted device (prosthesis) and the surrounding bone tissue, and effectively prevent the implantation infection caused by bacteria, prolong its service life, especially suitable for the treatment of patients with pathologically induced bone resorption and fractures, with good applicability , high application value.
下面通过附图和实施例对本发明的技术方案作进一步的详细描述。The technical solutions of the present invention will be described in further detail below with reference to the drawings and embodiments.
附图说明Description of drawings
图1为本发明实施例1的混合溶液B中纳米银的透射电镜图。Fig. 1 is a transmission electron microscope image of nano-silver in the mixed solution B of Example 1 of the present invention.
图2为本发明实施例1和对比例1~对比例2形成的各涂层及钛片中不同部位的抗菌效果对比图。Fig. 2 is a comparison diagram of the antibacterial effect of each coating formed in Example 1 of the present invention and Comparative Examples 1 to 2 and different parts of the titanium sheet.
具体实施方式Detailed ways
实施例1Example 1
本实施例包括以下步骤:This embodiment includes the following steps:
步骤一、将蚕丝放置于0.02M的Na2CO3溶液中煮沸40min,取出后采用去离子水冲洗,然后加入到60℃的9.3M的LiBr溶液中溶解4h,得到丝素蛋白原液;
将丝素蛋白原液采用去离子水稀释成质量浓度2%的丝素蛋白溶液,然后将17mg硝酸银粉末和4mg抗菌肽粉末加入到10mL质量浓度2%的丝素蛋白溶液中混合,得到含有丝素蛋白、银离子和抗菌肽且pH为8.5的混合溶液A;The silk fibroin stock solution is diluted with deionized water into a silk fibroin solution with a mass concentration of 2%, and then 17mg of silver nitrate powder and 4mg of antimicrobial peptide powder are added to 10mL of the silk fibroin solution with a mass concentration of 2% and mixed to obtain a silk fibroin solution containing 2% mass concentration. The mixed solution A of protein, silver ion and antimicrobial peptide and pH is 8.5;
步骤二、将步骤一中得到的混合溶液A放置于40W紫外灯下进行照射还原0.5h,使得混合溶液A的颜色逐渐由乳白色变为深棕色,得到含有丝素蛋白、纳米银和抗菌肽的混合溶液B;所述混合溶液B中纳米银的粒径为20nm,混合溶液B中具有β折叠结构的丝素蛋白的质量含量为15%;所述混合溶液A中抗菌肽的氨基酸序列为(NH2)-NGIVKAGPAIAVLGEAAL-CONH2,抗菌肽的质量纯度为99.99%;Step 2. Place the mixed solution A obtained in
步骤三、采用标准NaOH溶液将10mM的Tris(三羟甲基氨基甲烷)溶液标定至pH为8.5,然后加入盐酸多巴胺得到工作液,将钛片依次浸入丙酮、乙醇和去离子水中超声清洗15min,再浸入工作液中在避光条件下浸泡12h,得到表面具有聚多巴胺辅助层的钛片;所述工作液中盐酸多巴胺的浓度为2mg/mL;所述聚多巴胺辅助层的厚度为200nm;Step 3: Use standard NaOH solution to calibrate the 10mM Tris (trishydroxymethylaminomethane) solution to pH 8.5, then add dopamine hydrochloride to obtain the working solution, immerse the titanium sheet in acetone, ethanol and deionized water for 15 minutes and ultrasonically clean it. Immerse in the working solution again and soak for 12h under light-proof conditions to obtain a titanium sheet with a polydopamine auxiliary layer on the surface; the concentration of dopamine hydrochloride in the working solution is 2mg/mL; the thickness of the polydopamine auxiliary layer is 200nm;
步骤四、将步骤三中得到的表面具有聚多巴胺辅助层的钛片浸入步骤二中得到的混合溶液B中进行浸泡,取出放置于恒温干燥箱中,在60℃下干燥10min,在钛片表面形成含纳米银抗菌肽功能涂层;所述含纳米银抗菌肽功能涂层的厚度为1μm。Step 4. Soak the titanium sheet with the polydopamine auxiliary layer on the surface obtained in step 3 in the mixed solution B obtained in step 2, take it out and place it in a constant temperature drying oven, dry it at 60°C for 10 minutes, and place it on the surface of the titanium sheet A functional coating containing nano-silver antimicrobial peptide is formed; the thickness of the functional coating containing nano-silver antimicrobial peptide is 1 μm.
图1为本实施例的混合溶液B中纳米银的透射电镜图,图中黑色圆形颗粒为纳米银颗粒,直径约为20nm,黑色圆形颗粒周围的阴影部分为抗菌肽,从图1可以看出,抗菌肽在纳米银颗粒表面富集。Fig. 1 is the transmission electron microscope figure of nanometer silver in the mixed solution B of the present embodiment, and black round particle among the figure is nano silver particle, and diameter is about 20nm, and the shadow part around black round particle is antimicrobial peptide, can from Fig. 1 It can be seen that antimicrobial peptides are enriched on the surface of silver nanoparticles.
对比例1Comparative example 1
本对比例包括以下步骤:This comparative example includes the following steps:
步骤一、将蚕丝放置于0.02M的Na2CO3溶液中煮沸40min,取出后采用去离子水冲洗,然后加入到60℃的9.3M的LiBr溶液中溶解4h,得到丝素蛋白原液;
将丝素蛋白原液采用去离子水稀释成质量浓度2%的丝素蛋白溶液,然后将17mg硝酸银粉末加入到10mL质量浓度2%的丝素蛋白溶液中混合,得到含有丝素蛋白和银离子且pH为8.5的混合溶液A;The silk fibroin stock solution is diluted with deionized water into a silk fibroin solution with a mass concentration of 2%, and then 17mg of silver nitrate powder is added to 10mL of the silk fibroin solution with a mass concentration of 2% and mixed to obtain silk fibroin and silver ions. And the mixed solution A whose pH is 8.5;
步骤二、将步骤一中得到的混合溶液A放置于40W紫外灯下进行照射还原0.5h,使得混合溶液A的颜色逐渐由乳白色变为深棕色,得到含有丝素蛋白和纳米银的混合溶液B;所述混合溶液B中纳米银的粒径为20nm,混合溶液B中具有β折叠结构的丝素蛋白的质量含量为15%;所述混合溶液A中抗菌肽的氨基酸序列为(NH2)-NGIVKAGPAIAVLGEAAL-CONH2;Step 2. Place the mixed solution A obtained in
步骤三、采用标准NaOH溶液将10mM的Tris(三羟甲基氨基甲烷)溶液标定至pH为8.5,然后加入盐酸多巴胺得到工作液,将钛片依次浸入丙酮、乙醇和去离子水中超声清洗15min,再浸入工作液中在避光条件下浸泡12h,得到表面具有聚多巴胺辅助层的钛片;所述工作液中盐酸多巴胺的浓度为2mg/mL;所述聚多巴胺辅助层的厚度为200nm;Step 3: Use standard NaOH solution to calibrate the 10mM Tris (trishydroxymethylaminomethane) solution to pH 8.5, then add dopamine hydrochloride to obtain the working solution, immerse the titanium sheet in acetone, ethanol and deionized water for 15 minutes and ultrasonically clean it. Immerse in the working solution again and soak for 12h under light-proof conditions to obtain a titanium sheet with a polydopamine auxiliary layer on the surface; the concentration of dopamine hydrochloride in the working solution is 2mg/mL; the thickness of the polydopamine auxiliary layer is 200nm;
步骤四、将步骤三中得到的表面具有聚多巴胺辅助层的钛片浸入步骤二中得到的混合溶液B中进行浸泡,取出放置于恒温干燥箱中,在60℃下干燥30min,在钛片表面形成含纳米银功能涂层;所述含纳米银功能涂层的厚度为1μm。Step 4. Soak the titanium sheet with the polydopamine auxiliary layer on the surface obtained in step 3 in the mixed solution B obtained in step 2, take it out and place it in a constant temperature drying oven, dry it at 60°C for 30 minutes, and place it on the surface of the titanium sheet A functional coating containing nano-silver is formed; the thickness of the functional coating containing nano-silver is 1 μm.
对比例2Comparative example 2
本对比例包括以下步骤:This comparative example includes the following steps:
步骤一、将蚕丝放置于0.02M的Na2CO3溶液中煮沸40min,取出后采用去离子水冲洗,然后加入到60℃的9.3M的LiBr溶液中溶解4h,得到丝素蛋白原液;
将丝素蛋白原液采用去离子水稀释成质量浓度2%的丝素蛋白溶液,然后将4mg抗菌肽粉末加入到10mL质量浓度2%的丝素蛋白溶液中混合,得到含有丝素蛋白和抗菌肽且pH为8.5的混合溶液A;The silk fibroin stock solution is diluted with deionized water into a silk fibroin solution with a mass concentration of 2%, and then 4mg of antimicrobial peptide powder is added to 10mL of the silk fibroin solution with a mass concentration of 2% and mixed to obtain silk fibroin and antimicrobial peptides. And the mixed solution A whose pH is 8.5;
步骤二、将步骤一中得到的混合溶液A放置于40W紫外灯下进行照射0.5h,得到含有丝素蛋白和抗菌肽的混合溶液B;所述混合溶液B中具有β折叠结构的丝素蛋白的质量含量为15%,所述混合溶液A中抗菌肽的氨基酸序列为(NH2)-NGIVKAGPAIAVLGEAAL-CONH2,抗菌肽的质量纯度为99.99%;Step 2. Place the mixed solution A obtained in
步骤三、采用标准NaOH溶液将10mM的Tris(三羟甲基氨基甲烷)溶液标定至pH为8.5,然后加入盐酸多巴胺得到工作液,将钛片依次浸入丙酮、乙醇和去离子水中超声清洗15min,再浸入工作液中在避光条件下浸泡12h,得到表面具有聚多巴胺辅助层的钛片;所述工作液中盐酸多巴胺的浓度为2mg/mL;所述聚多巴胺辅助层的厚度为200nm;Step 3: Use standard NaOH solution to calibrate the 10mM Tris (trishydroxymethylaminomethane) solution to pH 8.5, then add dopamine hydrochloride to obtain the working solution, immerse the titanium sheet in acetone, ethanol and deionized water for 15 minutes and ultrasonically clean it. Immerse in the working solution again and soak for 12h under light-proof conditions to obtain a titanium sheet with a polydopamine auxiliary layer on the surface; the concentration of dopamine hydrochloride in the working solution is 2mg/mL; the thickness of the polydopamine auxiliary layer is 200nm;
步骤四、将步骤三中得到的表面具有聚多巴胺辅助层的钛片浸入步骤二中得到的混合溶液B中进行浸泡,取出放置于恒温干燥箱中,在60℃下干燥30min,在钛片表面形成含抗菌肽功能涂层;所述抗菌肽功能涂层的厚度为1μm。Step 4. Soak the titanium sheet with the polydopamine auxiliary layer on the surface obtained in step 3 in the mixed solution B obtained in step 2, take it out and place it in a constant temperature drying oven, dry it at 60°C for 30 minutes, and place it on the surface of the titanium sheet A functional coating containing antimicrobial peptides is formed; the thickness of the functional coatings containing antimicrobial peptides is 1 μm.
将钛片、实施例1在钛片表面形成的含纳米银抗菌肽功能涂层、对比例1在钛片表面形成的含纳米银功能涂层、对比例2在钛片表面形成的含抗菌肽功能涂层分别与金黄色葡萄球菌(1×108CFU)在37℃恒温箱中共培养24h,然后采用涂板法计数,分别统计共培养后的金黄色葡萄球菌数量,且钛片和每组涂层均分别对应选取两个不同部位即部位1和部位2进行抗菌效果观察。The nano-silver antimicrobial peptide-containing functional coating formed on the titanium sheet surface in Example 1, the nano-silver functional coating formed on the titanium sheet surface in Comparative Example 1, and the antimicrobial peptide-containing antimicrobial peptide formed on the titanium sheet surface in Comparative Example 2 The functional coatings were co-cultured with Staphylococcus aureus (1×10 8 CFU) in a 37°C incubator for 24 hours, and then counted by the plate method, and the number of Staphylococcus aureus after co-cultivation was counted, and the titanium sheet and each group The coatings were selected correspondingly to two different parts, namely
图2为本发明实施例1和对比例1~对比例2形成的各涂层及钛片中不同部位的抗菌效果对比图,图中的绿色点代表活细菌,红色点代表死细菌,从图2可看出,相较于对比例1~对比例2形成的各涂层及钛片,本发明实施例1中在钛片表面形成的含纳米银抗菌肽功能涂层共培养后的金黄色葡萄球菌数量最少,说明该含纳米银抗菌肽功能涂层具有优异的协同抗菌效果,且优于含纳米银功能涂层和含抗菌肽功能涂层。Fig. 2 is the contrast figure of the antibacterial effect of each coating and different parts in the titanium sheet that
实施例2Example 2
本实施例包括以下步骤:This embodiment includes the following steps:
步骤一、将蚕丝放置于0.02M的Na2CO3溶液中煮沸40min,取出后采用去离子水冲洗,然后加入到60℃的9.3M的LiBr溶液中溶解4h,得到丝素蛋白原液;
将丝素蛋白原液采用去离子水稀释成质量浓度3%的丝素蛋白溶液,然后将10mg硝酸银粉末和8mg抗菌肽粉末加入到10mL质量浓度3%的丝素蛋白溶液中混合,得到含有丝素蛋白、银离子和抗菌肽且pH为8的混合溶液A;The silk fibroin stock solution was diluted with deionized water into a silk fibroin solution with a mass concentration of 3%, and then 10 mg of silver nitrate powder and 8 mg of antimicrobial peptide powder were added to 10 mL of a silk fibroin solution with a mass concentration of 3% and mixed to obtain a silk fibroin solution containing 3% mass concentration. Protein, silver ion and antimicrobial peptide and the mixed solution A that pH is 8;
步骤二、将步骤一中得到的混合溶液A放置于40W紫外灯下进行照射还原1h,使得混合溶液A的颜色逐渐由乳白色变为深棕色,得到含有丝素蛋白、纳米银和抗菌肽的混合溶液B;所述混合溶液B中纳米银的粒径为300nm,混合溶液A中具有β折叠结构的丝素蛋白的质量含量为20%;所述混合溶液B中抗菌肽的氨基酸序列为(NH2)-NGIVKAGPAIAVLGEAAL-CONH2,抗菌肽的质量纯度为99.99%;Step 2. Place the mixed solution A obtained in
步骤三、采用标准NaOH溶液将10mM的Tris溶液标定至pH为8.5,然后加入盐酸多巴胺得到工作液,将钛合金依次浸入丙酮、乙醇和去离子水中超声清洗15min,再浸入工作液中在避光条件下浸泡18h,得到表面具有聚多巴胺辅助层的钛合金;所述工作液中盐酸多巴胺的浓度为2mg/mL;所述聚多巴胺辅助层的厚度为300nm;Step 3: Use standard NaOH solution to calibrate the 10mM Tris solution to pH 8.5, then add dopamine hydrochloride to obtain the working solution, immerse the titanium alloy in acetone, ethanol and deionized water for 15 minutes, and then immerse in the working solution in the dark Soaked under the conditions for 18 hours to obtain a titanium alloy with a polydopamine auxiliary layer on the surface; the concentration of dopamine hydrochloride in the working solution is 2mg/mL; the thickness of the polydopamine auxiliary layer is 300nm;
步骤四、将步骤三中得到的表面具有聚多巴胺辅助层的钛合金浸入步骤二中得到的混合溶液B中进行浸泡,取出放置于恒温干燥箱中,在60℃下干燥30min,在钛合金表面形成含纳米银抗菌肽功能涂层;所述含纳米银抗菌肽功能涂层的厚度为15μm。Step 4. Immerse the titanium alloy with polydopamine auxiliary layer on the surface obtained in step 3 into the mixed solution B obtained in step 2, take it out and place it in a constant temperature drying oven, dry it at 60°C for 30 minutes, and place it on the surface of the titanium alloy A functional coating containing nano-silver antimicrobial peptide is formed; the thickness of the functional coating containing nano-silver antimicrobial peptide is 15 μm.
实施例3Example 3
本实施例包括以下步骤:This embodiment includes the following steps:
步骤一、将蚕丝放置于0.02M的Na2CO3溶液中煮沸40min,取出后采用去离子水冲洗,然后加入到60℃的9.3M的LiBr溶液中溶解4h,得到丝素蛋白原液;
将丝素蛋白原液采用去离子水稀释成质量浓度5%的丝素蛋白溶液,然后将200mg硝酸银粉末和10mg抗菌肽粉末加入到10mL质量浓度5%的丝素蛋白溶液中混合,得到含有丝素蛋白、银离子和抗菌肽且pH为10的混合溶液A;Dilute the silk fibroin stock solution with deionized water into a silk fibroin solution with a mass concentration of 5%, then add 200 mg of silver nitrate powder and 10 mg of antimicrobial peptide powder into 10 mL of a silk fibroin solution with a mass concentration of 5% and mix to obtain a silk fibroin solution containing 5% mass concentration. Protein, silver ion and antimicrobial peptide and the mixed solution A that pH is 10;
步骤二、将步骤一中得到的混合溶液A放置于40W紫外灯下进行照射还原2h,使得混合溶液A的颜色逐渐由乳白色变为深棕色,得到含有丝素蛋白、纳米银和抗菌肽的混合溶液B;所述混合溶液B中纳米银的粒径为500nm,混合溶液B中具有β折叠结构的丝素蛋白的质量含量为30%;所述混合溶液A中抗菌肽的氨基酸序列为(NH2)-NGIVKAGPAIAVLGEAAL-CONH2,抗菌肽的质量纯度为99.99%;Step 2. Place the mixed solution A obtained in
步骤三、采用标准NaOH溶液将10mM的Tris溶液标定至pH为8.5,然后加入盐酸多巴胺得到工作液,将不锈钢依次浸入丙酮、乙醇和去离子水中超声清洗15min,再浸入工作液中在避光条件下浸泡24h,得到表面具有聚多巴胺辅助层的不锈钢;所述工作液中盐酸多巴胺的浓度为2mg/mL;所述聚多巴胺辅助层的厚度为500nm;Step 3: Use standard NaOH solution to calibrate the 10mM Tris solution to pH 8.5, then add dopamine hydrochloride to obtain the working solution, immerse the stainless steel in acetone, ethanol and deionized water for 15 minutes and ultrasonically clean it, then immerse it in the working solution under dark conditions Soak for 24 hours to obtain stainless steel with a polydopamine auxiliary layer on the surface; the concentration of dopamine hydrochloride in the working solution is 2mg/mL; the thickness of the polydopamine auxiliary layer is 500nm;
步骤四、将步骤三中得到的表面具有聚多巴胺辅助层的不锈钢浸入步骤二中得到的混合溶液B中进行浸泡,取出放置于恒温干燥箱中,在60℃下干燥30min,在不锈钢表面形成含纳米银抗菌肽功能涂层;所述含纳米银抗菌肽功能涂层的厚度为20μm。Step 4. Immerse the stainless steel with a polydopamine auxiliary layer on the surface obtained in step 3 into the mixed solution B obtained in step 2 for soaking, take it out and place it in a constant temperature drying oven, and dry it at 60° C. for 30 minutes to form a polydopamine-containing layer on the stainless steel surface. Nano silver antimicrobial peptide functional coating; the thickness of the nano silver antimicrobial peptide functional coating is 20 μm.
以上所述,仅是本发明的较佳实施例,并非对本发明作任何限制。凡是根据发明技术实质对以上实施例所作的任何简单修改、变更以及等效变化,均仍属于本发明技术方案的保护范围内。The above descriptions are only preferred embodiments of the present invention, and do not limit the present invention in any way. All simple modifications, changes and equivalent changes made to the above embodiments according to the technical essence of the invention still belong to the protection scope of the technical solution of the invention.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110193466.8A CN112972769B (en) | 2021-02-20 | 2021-02-20 | Method for preparing nano-silver-containing antibacterial peptide functional coating on metal surface |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110193466.8A CN112972769B (en) | 2021-02-20 | 2021-02-20 | Method for preparing nano-silver-containing antibacterial peptide functional coating on metal surface |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112972769A CN112972769A (en) | 2021-06-18 |
| CN112972769B true CN112972769B (en) | 2023-02-03 |
Family
ID=76393794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110193466.8A Active CN112972769B (en) | 2021-02-20 | 2021-02-20 | Method for preparing nano-silver-containing antibacterial peptide functional coating on metal surface |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112972769B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114053481A (en) * | 2021-09-18 | 2022-02-18 | 广东省华源康泰生物科技有限责任公司 | Preparation method of titanium-based bone dental implant material loaded with antibacterial polypeptide and antibacterial ions |
| CN115105634B (en) * | 2022-06-27 | 2023-09-19 | 西北有色金属研究院 | Process for preparing composite coating with timeliness for orthopedics |
| CN115721777A (en) * | 2023-01-09 | 2023-03-03 | 泉州师范学院 | A titanium alloy screw with polydopamine-adhered CuS/CaCO3 nanocomposite as antimicrobial coating |
| BE1031616B1 (en) * | 2023-10-27 | 2025-04-09 | Affiliated Hospital Of Youjiang Medical Univ For Nationalities | Antibacterial metal biomaterial, manufacturing process, and tissue holder for bone damage repair |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010141133A2 (en) * | 2009-03-04 | 2010-12-09 | Trustees Of Tufts College | Silk fibroin systems for antibiotic delivery |
| CN103816561A (en) * | 2014-02-24 | 2014-05-28 | 苏州大学 | Fibroin based double-layer antibiotic film and making method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1604697A1 (en) * | 2004-06-09 | 2005-12-14 | J.A.C.C. GmbH | Implantable device |
| FR3025106B1 (en) * | 2014-08-27 | 2017-12-08 | Dermaconcept Jmc | ANTIMICROBIAL COMPOSITION |
| CN104825385A (en) * | 2015-04-22 | 2015-08-12 | 天津大学 | Collagen-based nanometer silver antibacterial support and its preparation method and use |
| CN109464461B (en) * | 2018-10-30 | 2020-10-30 | 郑州大学 | Multifunctional antibacterial polypeptide modified nano-silver compound and preparation method thereof |
-
2021
- 2021-02-20 CN CN202110193466.8A patent/CN112972769B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010141133A2 (en) * | 2009-03-04 | 2010-12-09 | Trustees Of Tufts College | Silk fibroin systems for antibiotic delivery |
| CN103816561A (en) * | 2014-02-24 | 2014-05-28 | 苏州大学 | Fibroin based double-layer antibiotic film and making method thereof |
Non-Patent Citations (1)
| Title |
|---|
| Antimicrobial peptide-modified silver nanoparticles for enhancing the antibacterial efficacy;Wenxi Li;《RSC Advances》;20201021;38746-38754 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112972769A (en) | 2021-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112972769B (en) | Method for preparing nano-silver-containing antibacterial peptide functional coating on metal surface | |
| CN112451748B (en) | Method for preparing silk fibroin-based bimetal antibacterial coating | |
| Ding et al. | A dual-functional implant with an enzyme-responsive effect for bacterial infection therapy and tissue regeneration | |
| Guan et al. | Long-lasting bactericidal activity through selective physical puncture and controlled ions release of polydopamine and silver nanoparticles–loaded TiO2 nanorods in vitro and in vivo | |
| Zhao et al. | Antibacterial nano-structured titania coating incorporated with silver nanoparticles | |
| Zhang et al. | Antibacterial TiO2 coating incorporating silver nanoparticles by microarc oxidation and ion implantation | |
| CN102677125B (en) | Preparation method of active antibacterial composite coating on surface of titanium and titanium alloy medical instrument | |
| Samani et al. | In vitro antibacterial evaluation of sol–gel‐derived Zn‐, Ag‐, and (Zn+ Ag)‐doped hydroxyapatite coatings against methicillin‐resistant Staphylococcus aureus | |
| Zhang et al. | Evaluation of osteogenic and antibacterial properties of strontium/silver‐containing porous TiO2 coatings prepared by micro‐arc oxidation | |
| CN111529756B (en) | Preparation method of surface coating of orthopedic implant instrument | |
| CN100551450C (en) | A kind of preparation method of antibacterial bioactive titanium coating | |
| CN107661544B (en) | Antibacterial and osteopromoting composite functional porous orthopedic implant and preparation method thereof | |
| Ordikhani et al. | Surface modifications of titanium implants by multilayer bioactive coatings with drug delivery potential: antimicrobial, biological, and drug release studies | |
| CN113827771A (en) | Preparation method of silver polyphenol nanocomposite antibacterial particles supported on medical metal surface | |
| O'sullivan et al. | Deposition of substituted apatites with anticolonizing properties onto titanium surfaces using a novel blasting process | |
| CN105617460A (en) | Method for preparing nontoxic antibacterial coating on surface of medical implant material | |
| Hu et al. | Smart zwitterionic coatings with precise pH-responsive antibacterial functions for bone implants to combat bacterial infections | |
| CN112190767B (en) | Nano-antibacterial coating material based on nanogold cluster and preparation method thereof | |
| Pesode et al. | A review-recent advances on antibacterial coating on magnesium alloys by micro arc oxidation for biomedical applications | |
| Zhou et al. | Engineering Ga-doped mesoporous bioactive glass-integrated PEEK implants for immunomodulatory and enhanced osseointegration effects | |
| Soares et al. | Cytotoxicity and antibacterial efficacy of silver deposited onto titanium plates by low-energy ion implantation | |
| CN113430600B (en) | Preparation method of polypyrrole@nano copper/pamidronate disodium composite coating with osteoinduction and photo-thermal/copper synergistic antibacterial functions | |
| Li et al. | Antibacterial activity and cyto-/tissue-compatibility of micro-/nano-structured titanium decorated with silver nanoparticles | |
| Farmani et al. | Macroporous coating of silver-doped hydroxyapatite/silica nanocomposite on dental implants by EDTA intermediate to improve osteogenesis, antibacterial, and corrosion behavior | |
| Xue et al. | A highly efficient, low-toxic, wide-spectrum antibacterial coating designed for 3D printed implants with tailorable release properties |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |